Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02086890 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Electro-acupuncture and Transcorneal Electrical Stimulation (TES) for Retinitis Pigmentosa

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Dec 2025 to Dec 2026
    • Study completion date: Dec 2025 to Dec 2027
    • Start date: Aug 2014 to Aug 13, 2014
    v14
  2. Primary and study completion dates: Dec 2024 to Dec 2025v13
  3. Secondary endpoints reordered
    • Study description expanded, about 8 words
    v12
  4. Primary completion date: Dec 2021 to Dec 2024
    • Study completion date: Feb 2022 to Dec 2024
    v11
  5. Primary completion date: Jun 2020 to Dec 2021v10 Show 4 more changesShow less
    • Primary endpoint revised
    • Study completion date: Jun 2020 to Feb 2022
    • Secondary endpoints: 6 to 4
    • Study description expanded, about 80 words
Show 8 earlier versionsHide 8 earlier versions
  1. Primary and study completion dates: Jun 2019 to Jun 2020v9
  2. Phase: Phase 1/2 to Not applicable
    • Primary and study completion dates: Jun 2018 to Jun 2019
    • Study title shortened, about 7 words
    v8
  3. Publications: 1 to 4v7
  4. Primary and study completion dates: Jun 2016 to Jun 2018v6
  5. Primary and study completion dates: Jun 2015 to Jun 2016v5
  6. Re-verified, no change to tracked fieldsv4
  7. Start date: Mar 2014 to Aug 2014v3 Show 4 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: 24 to 21
    • Primary and study completion dates: Dec 2014 to Jun 2015
    • Site details revised
  8. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Measures of vision in RP patients receiving promising therapy using transcorneal electrical stimulation.
Trial Details
NCT Number NCT02086890
Lead Sponsor Nova Southeastern University
Collaborators: National Eye Institute (NEI)
Conditions
(from sponsor)		 Retinitis Pigmentosa
Related terms Retinitis Pigmentosa
Enrollment 21 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov